Abstract
BackgroundLocalized ablative immunotherapies hold great promise in stimulating antitumor immunity to treat metastatic and poorly immunogenic tumors. Tumor ablation is well known to release tumor antigens and danger-associated molecular patterns...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have